Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 510 and 558
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for an approved new animal drug application (NADA) from Alpharma Inc., to Pharmaq AS.  The drug labeler code for Pharmaq AS is also being listed.
 DATES: This rule is effective September 2, 2005.
 FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: 
                        *david.newkirk@fda.gov*.


SUPPLEMENTARY INFORMATION: Alpharma Inc., One Executive Drive, Fort Lee, NJ 07024, has informed FDA that it has transferred ownership of, and all rights and interest in, NADA 125-933 for ROMET-30 (sulfadimethoxine/ormetoprim) Type A medicated article to Pharmaq AS, Skogmo Industriomrade, N-7863 Overhalla, Norway.  Accordingly, the agency is amending the regulations in 21 CFR 558.575 to reflect the transfer of ownership. In addition, Pharmaq AS has not been previously listed in the animal drug regulations as a sponsor of an approved application.  Accordingly, 21 CFR 510.600(c) is being amended to add entries for Pharmaq AS. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.”  Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 510 Administrative practice and procedure
Animal drugs
Labeling
Reporting and recordkeeping requirements 21 CFR Part 558 Animal drugs
Animal feeds
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 558 are amended as follows: PART 510—NEW ANIMAL DRUGS
 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority:
                        21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.60o is amended in the table in paragraph (c)(1) by alphabetically adding a new entry for “Pharmaq AS” and in the table in paragraph (c)(2) by numerically adding a new entry for “015331” to read as follows: § 510.600
 
 (c)  * * * (1)  * * * Firm name and address
Drug labeler code*    *    *    *    *Pharmaq AS, Skogmo Industriomrade, N-7863 Overhalla, Norway.
015331*    *    *    *    *
 
 
 (2) * * * Drug labeler code
Firm name and address*    *    *    *    *015331
Pharmaq AS, Skogmo Industriomrade, N-7863 Overhalla, Norway.*    *    *    *    *
 PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
 3.The authority citation for 21 CFR part 558 continues to read as follows: Authority:
                        21 U.S.C. 360b, 371. § 558.575
 4.Section 558.575 is amended in paragraph (a)(2) by removing “046573” and by adding in its place “No. 015331”. Dated: August 22, 2005. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.


[FR Doc. 05-17472  Filed 9-1-05; 8:45 am] BILLING CODE 4160-01-S